Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)

Let's delve deeper.

If we compare the Operating Profit margins of most of the pharmaceutical companies in India (domestic as well as MNC players) they are more or less in the 19-23% bracket. But when it comes to ROCE, the MNC pack is clearly the outperformer. Let’s have a look here.